Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrator complex subunit 11 (INTS11) is an RNA endonuclease and a key catalytic component of the multi-protein Integrator complex, which regulates the 3′-end processing and transcriptional termination of noncoding RNAs and a subset of protein-coding genes by RNA polymerase II. INTS11 belongs to the metallo-β-lactamase superfamily and forms a stable, functionally essential complex with Integrator complex subunit 9 (INTS9) through their C-terminal domains. The Integrator complex acts as a molecular checkpoint during transcription, promoting termination and degradation of nascent RNA when elongation is unfavorable. Disruption of INTS11 function leads to transcriptional readthrough, misprocessing of snRNAs, and global dysregulation of gene expression. INTS11 has been implicated in neurodevelopmental disease, and research continues into its role in cancer and other transcription-mediated disorders.
Not fully elucidated in current literature, but hypothetical mechanisms could involve inhibition of RNA endonuclease activity, affecting 3′ end RNA processing and transcription termination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 11 (INTS11).